Author:
Hussain Md Sadique,Moglad Ehssan,Afzal Muhammad,Bansal Pooja,Kaur Harpreet,Deorari Mahamedha,Ali Haider,Shahwan Moyad,Hassan almalki Waleed,Kazmi Imran,Alzarea Sami I.,Singh Sachin Kumar,Dua Kamal,Gupta Gaurav
Reference171 articles.
1. Targeting the KRAS Pathway in Non-Small Cell Lung Cancer;Tomasini;Oncologist,2016
2. Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics;Zhang;Expert Rev. Respir. Med.,2023
3. KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine;Coupez;Expert Opin. Biol. Ther.,2021
4. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting;Bhat;Pathol., Res. Pract.,2023
5. The current state of the art and future trends in RAS-targeted cancer therapies, Nature reviews;Punekar;Clin. Oncol.,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献